Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease prostate cancer
Symptom C0015672|fatigue
Sentences 21
PubMedID- 25506196 Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancer.
PubMedID- 23047795 Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy.
PubMedID- 21358092 Background: limited information is available regarding the long-term effect of external beam radiotherapy (ebrt) on fatigue in individuals with prostate cancer (pc).
PubMedID- 24786901 Objectives: this prospective study explored relationships between expression changes of genes related to mitochondrial biogenesis/bioenergetics and fatigue in men with prostate cancer receiving external beam radiation therapy (ebrt).
PubMedID- 23837903 This study provides preliminary evidence to indicate that prostate cancer patients with better baseline fatigue and patients whose dyspnea and cognitive functioning improves within 3 months of treatment are at a significantly decreased risk of mortality.
PubMedID- 24237792 Health professionals require knowledge of a range of effective interventions aimed at reducing cancer-related fatigue in men with prostate cancer and should incorporate those interventions into their patient management.
PubMedID- 21252643 Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy.
PubMedID- 20687221 fatigue in prostate cancer survivors treated with definitive radiotherapy and lhrh analogs.
PubMedID- 23152362 Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy.
PubMedID- 20665492 To date, however, there are no published controlled trials of interventions for fatigue in men with prostate cancer.
PubMedID- 21448299 Levels of prostate serum antigen and testosterone remained unchanged, indicating that resistance training can be safely tolerated in men receiving adt.30,31 segal et al recently demonstrated in a randomized controlled study that resistance and aerobic exercise alleviate fatigue in men with prostate cancer receiving radiation therapy with or without adt.
PubMedID- 23455492 The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature.
PubMedID- 23089339 Background: androgen deprivation therapy (adt) for prostate cancer (pca) is associated with weakness, fatigue, sarcopenia, and reduced quality of life (qol).
PubMedID- 21454042 Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy.
PubMedID- 24684534 Phase ii, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving lhrh-agonist therapy.
PubMedID- 22475653 Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.
PubMedID- 22007078 Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy.
PubMedID- PMC3135319 48. mitochondria-related gene expression changes are associated with fatigue in patients with non-metastatic prostate cancer receiving external beam radiation therapy.
PubMedID- 25699239 (11) reported significant reduction in severe urinary frequency, diarrhea, and fatigue in patients with prostate cancer who were treated with igrt (n = 265) compared with patients not treated with igrt (n = 26).
PubMedID- 24825734 Purpose: a multi-centre, longitudinal study was conducted to assess the prevalence of fatigue amongst men with localized prostate cancer, to describe several dimensions of fatigue and to explore the predictability of fatigue by psychological distress and physical function.
PubMedID- 24054763 Comparing expression (mrna) of many fatigue-related genes in patients with adt-treated prostate cancer versus with cfs versus healthy controls, and correlating mrna with fatigue severity may clarify the differing pathways underlying fatigue in these conditions.

Page: 1